HIV disease prevention and treatment. A model for local planning. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HIV disease prevention and treatment. A model for local planning.

West J Med. 1988 Oct;149(4):481-5. Unique Identifier : AIDSLINE MED/89147276
Kizer KW; Conant MA; Francis DP; Fraziear T

Abstract: Since first reported in 1981, about a fourth of all cases of the acquired immunodeficiency syndrome in the United States have occurred in California. In response to the human immunodeficiency virus (HIV) epidemic, California has developed a five-point strategy consisting of epidemiologic surveillance; prevention education; the provision of medical treatment and supportive services; research; and continuous planning, evaluation, and coordination of programs. Given the size and tremendous environmental and cultural diversity of California, as well as the variable local impact of HIV disease local jurisdictions need to develop HIV disease prevention and treatment plans specifically tailored to the circumstances of their communities. At a minimum, these plans should include central participatory planning, epidemiologic surveillance, HIV antibody testing and prevention education programs, provision for medical treatment and social support services, and coordination of financing mechanisms. We present a model for such plans.
Keywords: Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL California Community Health Services/*TRENDS Disease Outbreaks/*PREVENTION & CONTROL Health Planning/*TRENDS Human *HIV JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDprevention&controlcaliforniacommunityhealthservices/KWDtrendsdiseaseoutbreaks/KWDprevention&controlhealthplanning/KWDtrendshumanKWDhivjournalarticle
890630
M8960549

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .